CIPROFIBRATE

SynDRA canonical compound SYN0019791 — structure-anchored drug synonym record

Clinical phase	Launched
Primary target(s)	PPARA
Mechanism of action	PPAR receptor agonist
Indication	hyperlipidemia
Disease area	endocrinology

All known targets

PPARA
LPL

Mechanisms of action (all sources)

PPAR receptor agonist
PPARA AGONIST
Peroxisome proliferator-activated receptor alpha agonist

Bioactivity evidence (ChEMBL activities table — not curator-asserted)

Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)

CP2C9

Drug classes

Antimetabolites
Carcinogens
Hypolipidemic Agents
Lipid Regulating Agents
Noxae
Peroxisome Proliferators

ATC classes

C10A · LIPID MODIFYING AGENTS, PLAIN

Cross-references

PubChem CID: 2763
ChEMBL: CHEMBL557555
DrugBank: DB09064
ChEBI: CHEBI:50867
KEGG: D03521
RxNorm: 21149
Wikipedia: Ciprofibrate
TTD: D0EJ6O
LINCS BRD: BRD-A49358627

Synonyms

lipanor
oroxadin
Ciprofibrato
NSC-759617
WIN-35833
Modalim
Ciprofibratum
Ciprol
Hiperlipen
Hyperlipen
Lipanor
Oroxadin
Sanofi Synthelabo brand of ciprofibrate
Sanofi Winthrop brand of ciprofibrate
C 0330
Win-35833
Ciprofibrato [INN-Spanish]
Ciprofibratum [INN-Latin]
Win 35,833
Ciprofibrate (USAN/INN)
Ciprofibrate [USAN:BAN:INN]
2-(4-(2,2-Dichlorocyclopropyl)phenoxy)2-methylpropanoic acid
2-(p-(2,2-Dichlorocyclopropyl)phenoxy)-2-methylpropionic acid
2-[4-(2,2-Dichlorocyclopropyl)phenoxy]-2-methylpropanoic acid
2-[p-(2,2-Dichlorocyclopropyl)phenoxy]-2-methylpropanoic acid
2-{4-[2,2-dichlorocyclopropyl]phenoxy}-2-methylpropanoic acid
2-{[4-(2,2-dichlorocyclopropyl)phenyl]oxy}-2-methylpropanoic acid
2-(4-(2,2-dichlorocyclopropyl)phenoxy)-2-methylpropanoic acid
Propanoic acid, 2-[4-(2,2-dichlorocyclopropyl)phenoxy]-2-methyl-
MFCD00467135
NSC 759617
F8252JGO9S
CHEBI:50867
Propanoic acid, 2-(4-(2,2-dichlorocyclopropyl)phenoxy)-2-methyl-
NCGC00164447-01
SMR000857190
CCRIS 173
SR-01000075734

Look up CIPROFIBRATE in the interactive SynDRA portal →